Just a reminder that Euroz Hartleys had anticipated our current SP to be sitting somewhere between 0.90c and $1.90 upon successful completion of phase 1 trials assuming no dilution.
This report was produced on 07/04/2022 when AGN was trading at 0.64c, since which we've had no dilution. compare that to our current SP of $0.48c and we're currently trading at an NPV discount of 53.33% relative to the anticipated 90c minimum.
Reminds me of the 'Expert Wall Street traders' predictions for the DJO for 2022.
Ann: Successful Completion of Phase 1 Clinical Trial Dosing, page-19
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.0¢ |
Change
0.020(2.44%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 84.0¢ | 81.5¢ | $47.21K | 57.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1458 | 82.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.0¢ | 4346 | 2 |
View Market Depth
| Last trade - 10.58am 03/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |